Annovis Bio, Inc.

ANVS · NYSE · SIC 2834: Pharmaceutical Preparations
128
SEC Filings

Business Summary

PART I . Our Company We are a late-stage clinical drug platform company addressing neurodegeneration, such as Alzheimers disease (AD) and Parkinsons disease (PD). We are developing our lead product candidate, buntanetap, which is designed to address AD, PD, and potentially other chronic neurodegenerative diseases. Buntanetap is a synthetically produced small molecule, orally administered, brain penetrant compound. In several studies, buntanetap was observed to inhibit the synthesis of neurotoxic...

Next Earnings

Q2 FY2026 — expected 2026-09-18

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionANVSdiscussed_in_filing Cybersecurity
topic_mentionANVSdiscussed_in_filing Trusted Computing
topic_mentionANVSdiscussed_in_filing Blockchain & Crypto
topic_mentionANVSdiscussed_in_filing Autonomous Vehicles
topic_mentionANVSdiscussed_in_filing Regulation
topic_mentionANVSdiscussed_in_filing Healthcare & Bio
topic_mentionANVSdiscussed_in_filing Platform & Ecosystem
topic_mentionANVSdiscussed_in_filing Sovereign & Government
topic_mentionANVSdiscussed_in_filing Cybersecurity
topic_mentionANVSdiscussed_in_filing Trusted Computing
topic_mentionANVSdiscussed_in_filing Blockchain & Crypto
topic_mentionANVSdiscussed_in_filing Autonomous Vehicles
topic_mentionANVSdiscussed_in_filing Regulation
topic_mentionANVSdiscussed_in_filing Healthcare & Bio
topic_mentionANVSdiscussed_in_filing Platform & Ecosystem
topic_mentionANVSdiscussed_in_filing Sovereign & Government
topic_mentionANVSdiscussed_in_filing Cybersecurity
topic_mentionANVSdiscussed_in_filing Trusted Computing
topic_mentionANVSdiscussed_in_filing Blockchain & Crypto
topic_mentionANVSdiscussed_in_filing Autonomous Vehicles

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-132025-12-310001104659-26-027751EDGAR80K words
2025-03-212024-12-310001558370-25-003482EDGAR—
2024-03-292023-12-310001558370-24-004393EDGAR—
2023-03-312022-12-310001104659-23-040275EDGAR—
2022-03-022021-12-310001558370-22-002668EDGAR—
2021-03-032020-12-310001558370-21-002303EDGAR—
2020-03-252019-12-310001104659-20-038326EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001104659-25-110393EDGAR17K words
2025-08-122025-06-300001558370-25-011233EDGAR—
2025-05-132025-03-310001558370-25-007584EDGAR—
2024-11-082024-09-300001558370-24-015074EDGAR—
2024-08-142024-06-300001558370-24-012227EDGAR—
2024-05-102024-03-310001558370-24-007820EDGAR—
2023-11-082023-09-300001558370-23-018298EDGAR—
2023-08-142023-06-300001558370-23-014884EDGAR—
2023-05-102023-03-310001558370-23-009142EDGAR—
2022-11-082022-09-300001558370-22-016902EDGAR—
2022-08-082022-06-300001558370-22-012561EDGAR—
2022-05-042022-03-310001558370-22-006981EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-250001104659-26-034611EDGAR1K words
2026-03-160001104659-26-028574EDGAR—
2026-02-120001104659-26-013948EDGAR—
2026-01-280001104659-26-007423EDGAR—
2025-11-130001104659-25-110548EDGAR—
2025-10-280001104659-25-103254EDGAR—
2025-10-140001104659-25-099356EDGAR—
2025-09-290001104659-25-094522EDGAR—
2025-08-150001104659-25-079248EDGAR—
2025-08-120001104659-25-076851EDGAR—

128 total filings indexed. 99 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001477845
TickerANVS
ExchangeNYSE
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: f4c0e968bac769102776620eebf1c3a4b96c62f60ba54cbb6a655e332f747686
parent: b56620fb4f5674a6de9ff582b687360814a877849a190b7bb5e1ec7bd02edc1c
content hash: eb32d19c3a502760656774e94d117f7f14f829af6a4a12bf54253906e17d9e36
signed: 2026-04-13T04:43:40.029Z
sources: 19 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf